SAN JOSE, Calif., July 23, 2019 /PRNewswire/ -- Ablative Solutions, Inc., a company pioneering new approaches to the treatment of hypertension, today announced the enrollment and randomization of the first patient in the TARGET BP I global clinical trial. Piedmont Heart Institute in Atlanta is the first hospital center worldwide to enroll

BERKELEY, Calif., July 23, 2019 /PRNewswire/ -- Today, the U.S. Patent and Trademark Office has awarded two new patents to the University of California (UC), University of Vienna, and Dr. Emmanuelle Charpentier covering methods of the CRISPR-Cas9 gene-editing technology.

ST. LOUIS, July 23, 2019 /PRNewswire/ -- Centene Corporation (NYSE: CNC) announced today its financial results for the second quarter ended June 30, 2019, reporting diluted earnings per share (EPS) of $1.18, and Adjusted Diluted EPS of $1.34.In summary, the 2019 second quarter results were as follows

TEL AVIV, Israel, July 23, 2019 /PRNewswire/ -- Stero Biotechs, an Israel-based, clinical-stage company focused on Cannabidiol (CBD) formulation research and development, received its second Helsinki approval to move forward with a second Phase 2a clinical trial. The trial will be a randomized, double-blin

SEATTLE and VANCOUVER, British Columbia, July 23, 2019 /PRNewswire/ -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company focused on nicotine addiction, today announced it has extended its strategic collaboration with the National Center for Complementary and Integrative Health (NCCIH) at the National

SYRACUSE, N.Y., July 23, 2019 /PRNewswire/ -- HealtheConnections, a regional health improvement organization in New York state, recently introduced their value-based care analytics tool myData. The application allows healthcare providers to easily access and understand comprehensive data in their patients' profiles, identify gaps in

MINNEAPOLIS, July 23, 2019 /PRNewswire/ -- Key Surgical LLC, a leading global provider of sterile processing and operating theatre supplies, announced today that it has signed an agreement

SEOUL, South Korea, July 23, 2019 /PRNewswire/ -- Innopresso, a member company of the

TIANJIN, China, July 23, 2019 /PRNewswire/ -- In a significant milestone toward obtaining key regulatory approvals for the BuMA Supreme Drug-Eluting Stent (DES) System, SINOMED has completed enrollment in the PIONEER III randomized, controlled clinical trial.  The PIONEER III trial is designed to assess the safety and effectiveness of the BuMA Supreme DES and suppor

SHANGHAI, July 23, 2019 /PRNewswire/ -- CPhI and P-MEC China – organized by China Chamber of Commerce for Import & Export of Medicines & Health Products (CCCMHPIE), Informa Markets, and Shanghai Sinoexpo Informa Markets – saw record numbers of attendees as the pharma market in